Utama › Serangan Jantung › Alabama
Kajian klinikal Serangan Jantung di Alabama
3 kajian untuk Serangan Jantung sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology of North Alabama, Decatur
- Nephrology Consultants, LLC, Huntsville
- DaVita Clinical Research Montgomery, Montgomery
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- SEC Clinical Research LLC, Andalusia
- Heart Center Research Llc, Huntsville
- Mobile Heart Specialists, Mobile
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Advanced Cardiovascular LLC, Alexander City
- University of Alabama Birmingham Saint Vincents Birmingham, Birmingham
- Birmingham Clinical Research, Birmingham
- dan 4 lagi
Mengambil pesertaFasa 3
Umur 50 hingga 105 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07136012Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.